Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Navarro Almario

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2022
Informatics in Medical Product Regulation: The Right Drug at the Right Dose for the Right PatientEileen Navarro Almario, Anna Kettermann, Vaishali Popat
Therapeutic Innovation & Regulatory Science|November 7, 2025
Navigating the Future: Considerations for use of Continuous Glucose Monitoring in Diabetes TrialsAnna Kettermann, Gauri Dandi, Jennifer Clark, et al.
Drug Safety|April 20, 2024
Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline ValuesBereket Tesfaldet, Tejas Patel, Minjun Chen, et al.
Drug Safety|February 11, 2025
Emerging Tools to Support DILI Assessment in Clinical Trials with Abnormal Baseline Serum Liver Tests or Pre-existing Liver DiseasesJasmine Amirzadegan, Bereket Tesfaldet, Y Veronica Pei, et al.
Drug Safety|August 31, 2025
R Value-Based Criteria Outperform Alkaline Phosphatase Less than Twice Normal in Identifying Hy's Law Cases in Clinical TrialsJasmine Amirzadegan, Edwige Chiogo Vouffo, Ling Lan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2022
Informatics in Medical Product Regulation: The Right Drug at the Right Dose for the Right PatientEileen Navarro Almario, Anna Kettermann, Vaishali Popat
Therapeutic Innovation & Regulatory Science|November 7, 2025
Navigating the Future: Considerations for use of Continuous Glucose Monitoring in Diabetes TrialsAnna Kettermann, Gauri Dandi, Jennifer Clark, et al.
Drug Safety|April 20, 2024
Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline ValuesBereket Tesfaldet, Tejas Patel, Minjun Chen, et al.
Drug Safety|February 11, 2025
Emerging Tools to Support DILI Assessment in Clinical Trials with Abnormal Baseline Serum Liver Tests or Pre-existing Liver DiseasesJasmine Amirzadegan, Bereket Tesfaldet, Y Veronica Pei, et al.
Drug Safety|August 31, 2025
R Value-Based Criteria Outperform Alkaline Phosphatase Less than Twice Normal in Identifying Hy's Law Cases in Clinical TrialsJasmine Amirzadegan, Edwige Chiogo Vouffo, Ling Lan, et al.
Pageof 1